Læknablaðið - 15.04.2012, Blaðsíða 30

Y F I R L I T
Heimildir
1. Strom BL, editor. Pharmacoepidemiology. Third ed. John
Wiley & Sons, Chichester 2000.
2. Yang Y, West-Strum D, editors. Understanding Pharma-
coepidemiology. McGraw-Hill, New York 2011.
3. Hennekens CH, Buring JE. Epidemiology in medicine.
Little Brown and Company, Boston/Toronto 1987.
4. Arrebola-Pascual I, Garcia-Lopez JA. Presence of pharma-
coepidemiology in three bibliographic databases: Medline,
IPA and SCI. Pharmacoepidem Dr S 2002; 11: 499-502.
5. Heman MA. With great data comes great responsibility:
publishing comparative effectiveness research in epi-
demiology. Epidemiology 2011; 22:290-1.
6. Hennessy S. Use of health care databases in pharmacoepi-
demiology. Basic Clin Pharmacol Toxicol 2006; 98: 311-3.
7. Öryggisstefna landlæknis. landlaeknir.is - ágúst 2011.
8. Ábyrgðaraðilar gagnasafna. Munnlegar heimildir.
9. Smith AJ, Tett SE. How do different age groups use benzo-
diazepines and antidepressants? Analysis of an Australian
administrative database, 2003-6. Drugs Aging 2009; 26:
113-22.
10. Gudbjornsson B, Thorsteinsson SB, Sigvaldason H, Einars-
dottir R, Johannsson M, Zoega H, et al. Rofecoxib, but not
celecoxib, increases the risk of thromboembolic cardiovas-
cular events in young adults-a nationwide registry-based
study. Eur J Clin Pharmacol 2010; 66: 619-25.
11. Landlæknisembættið. landlaeknir.is/ - ágúst 2011.
12. Krabbameinsskrá íslands. krabbameinsskra.is - ágúst 2011.
13. Fæðingaskrá. landspitali.is/gagnasafn?branch=4810.5075
ágúst 2011.
14. Hjartavemd. hjarta.is/ - ágúst 2011.
15. Lyfjastofnun. lyfjastofnun.is/ -ágúst2011.
16. Hagstofa íslands. hagstofa.is/ - ágúst 2011.
17. Slysaskrá Vinnueftirlitsins. slysatolfraedi.ver.is/um.aspx -
ágúst 2011.
18. Corrao G, Botteri E, Bagnardi V, Zambon A, Carobbio
A, Falcone C, et al. Generating signals of drug-adverse
effects from prescription databases and application to
the risk of arrhythmia associated with antibacterials.
Pharmacoepidem Dr S 2005; 14: 31-40.
19. Brinker A, Beitz J. Use of a spontaneous adverse drug
events database for identification of unanticipated drug
benefits. Clin Pharmacol Ther 2002; 71:99-102.
20. Brandt-Christensen M, Kvist K, Nilsson FM, Andersen
PK, Kessing LV. Treatment with antidepressants and
lithium is associated with increased risk of treatment with
antiparkinson dmgs: a pharmacoepidemiological study. J
Neurol Neurosurg Psychiatry 2006; 77: 781-3.
21. Delaney JA, Opatmy L, Brophy JM, Suissa S. Confounding
in database pharmacoepidemiology studies. Epidemiology
2008; 19:360-1.
22. Vísindasiðanefnd. visindasidanefnd.is/ - ágúst 2011.
23. Persónuvemd. personuvemd.is/ - ágúst 2011.
ENGLISH SUMMARY
Research in pharmacoepidemiology in lceland
Johannsson M, Haraldsdottir S
Pharmacoepidemiology is a rapidly growing discipline that is useful
in studies on effects and adverse effects of drugs. During past years
and decades databases have been built in lceland that are becoming
powerful tools for this kind of research. The databases are, however
only useful for pharmacoepidemiological research if they include
personal identification and can be merged. The personal identification
should be without time limits because in many cases we are interested
in what happened years or decades ago. The prescriptions database
was started in 2002 and has dramatically changed the possibilities
for pharmacoepidemiological studies in lceland. The main aim of this
review is to give an overview of the existing databases in lceland and to
encourage research in this important field.
Key words: pharmacoepidemiology, research, databases, drugs.
Correspondence. Magnús Jóhannsson, magjoh@hi.is
’Department of Pharmacology and Toxicotogy, University of lceland, 2Directorate of Health
Styrkir til rannsókna
vegna eyrnasuðs (tinnitus)
Liljusjóðurinn, rannsóknar- og styrktarsjóður Lilju Guðrúnar Hannesdóttur
Tilgangur sjóðsins er að styrkja rannsóknir á eyrnasuði. Tilgangur rannsókna skal vera sá að afla allrar
vitneskju sem hægt er til að komast að ástæðum þess að fólk þjáist af eyrnasuði.
Umsóknarfrestur er til 23. apríl 2012.
Úthlutað verður úr sjóðnum á afmælisdegi Lilju Guðrúnar, 24. maí.
Umsóknareyðublöð má nálgast á heimasíðu sjóðsins liljusjodurinn.is eða hjá undirrituðum.
Hannes Petersen, dósent - hpet@landspitali.is
Ingibjörg Hinriksdóttir - ingibjorg@hti.is
222 LÆKNAblaðið 2012/98